FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2004507310> ?p ?o ?g. }

• W2004507310 endingPage "723" @default.
• W2004507310 startingPage "723" @default.
• W2004507310 abstract "Partial epilepsy comprises simple partial seizures, complex partial seizures, and secondarily generalized seizures, and covers more than 60% of patients with epilepsy. Antiepileptic drugs are generally considered to be the major therapeutic intervention for epilepsy but, despite a broad range of commonly used antiepileptic drugs, approximately 30% of adult patients and approximately 25% of children with epilepsy have inadequate seizure control. Eslicarbazepine acetate (ESL) is a novel voltage-gated sodium channel-blocking agent with presumed good safety and efficacy for adjunctive treatment of patients with drug-resistant partial epilepsy. ESL is a prodrug of eslicarbazepine (the active entity responsible for pharmacologic effects), and is rapidly and extensively hydrolyzed during first pass by liver esterases after oral administration. The half-life of eslicarbazepine at steady-state plasma concentrations is 20-24 hours, compatible with once-daily administration. ESL 800 mg and 1200 mg significantly reduces seizure frequency and shows a favorable safety profile in adult patients with drug-resistant partial-onset seizures, as demonstrated in previous Phase II and III trials. In children, ESL showed a clear dose-dependent decrease in seizure frequency with good tolerability. The most commonly reported adverse events associated with ESL are dizziness, somnolence, nausea, diplopia, headache, vomiting, blurred vision, vertigo, and fatigue. In conclusion, these characteristics suggest that ESL might be a valid and well tolerated treatment option for patients with drug-resistant partial-onset epilepsy. The convenience of once-daily dosing and a short, simple titration regimen would be of special interest for children, although conclusive published data are lacking to date. Hence, there is an urgent need to establish the therapeutic value of ESL in this special population in the near future." @default.
• W2004507310 created "2016-06-24" @default.
• W2004507310 creator A5025863413 @default.
• W2004507310 creator A5084045857 @default.
• W2004507310 date "2010-11-01" @default.
• W2004507310 modified "2023-10-14" @default.
• W2004507310 title "Update on treatment of partial onset epilepsy: role of eslicarbazepine" @default.
• W2004507310 cites W110578008 @default.
• W2004507310 cites W1557552045 @default.
• W2004507310 cites W1572262481 @default.
• W2004507310 cites W1892429132 @default.
• W2004507310 cites W1968259409 @default.
• W2004507310 cites W1974809694 @default.
• W2004507310 cites W1975172643 @default.
• W2004507310 cites W1976554010 @default.
• W2004507310 cites W1978285852 @default.
• W2004507310 cites W1978865140 @default.
• W2004507310 cites W1980087402 @default.
• W2004507310 cites W1983532383 @default.
• W2004507310 cites W1984234523 @default.
• W2004507310 cites W1987961531 @default.
• W2004507310 cites W1992770589 @default.
• W2004507310 cites W1995660607 @default.
• W2004507310 cites W2003186780 @default.
• W2004507310 cites W2006258730 @default.
• W2004507310 cites W2007403037 @default.
• W2004507310 cites W2015497142 @default.
• W2004507310 cites W2024607510 @default.
• W2004507310 cites W2025684343 @default.
• W2004507310 cites W2042774009 @default.
• W2004507310 cites W2055001654 @default.
• W2004507310 cites W2063440034 @default.
• W2004507310 cites W2073245622 @default.
• W2004507310 cites W2084410352 @default.
• W2004507310 cites W2089818590 @default.
• W2004507310 cites W2090448122 @default.
• W2004507310 cites W2096695182 @default.
• W2004507310 cites W2109577708 @default.
• W2004507310 cites W2114440648 @default.
• W2004507310 cites W2120091670 @default.
• W2004507310 cites W2126829625 @default.
• W2004507310 cites W2132257746 @default.
• W2004507310 cites W2132812107 @default.
• W2004507310 cites W2134306772 @default.
• W2004507310 cites W2154604038 @default.
• W2004507310 cites W2165021119 @default.
• W2004507310 cites W2630443280 @default.
• W2004507310 cites W2689267561 @default.
• W2004507310 cites W3192094271 @default.
• W2004507310 cites W39094740 @default.
• W2004507310 cites W6801438 @default.
• W2004507310 cites W2154863327 @default.
• W2004507310 doi "https://doi.org/10.2147/ndt.s5840" @default.
• W2004507310 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2987506" @default.
• W2004507310 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21127691" @default.
• W2004507310 hasPublicationYear "2010" @default.
• W2004507310 type Work @default.
• W2004507310 sameAs 2004507310 @default.
• W2004507310 citedByCount "8" @default.
• W2004507310 countsByYear W20045073102012 @default.
• W2004507310 countsByYear W20045073102018 @default.
• W2004507310 countsByYear W20045073102020 @default.
• W2004507310 crossrefType "journal-article" @default.
• W2004507310 hasAuthorship W2004507310A5025863413 @default.
• W2004507310 hasAuthorship W2004507310A5084045857 @default.
• W2004507310 hasBestOaLocation W20045073101 @default.
• W2004507310 hasConcept C118552586 @default.
• W2004507310 hasConcept C126322002 @default.
• W2004507310 hasConcept C141071460 @default.
• W2004507310 hasConcept C178790620 @default.
• W2004507310 hasConcept C185592680 @default.
• W2004507310 hasConcept C187212893 @default.
• W2004507310 hasConcept C197934379 @default.
• W2004507310 hasConcept C2776414672 @default.
• W2004507310 hasConcept C2777803345 @default.
• W2004507310 hasConcept C2778186239 @default.
• W2004507310 hasConcept C2778375690 @default.
• W2004507310 hasConcept C2779034229 @default.
• W2004507310 hasConcept C2779159986 @default.
• W2004507310 hasConcept C2780580376 @default.
• W2004507310 hasConcept C2780581723 @default.
• W2004507310 hasConcept C3018162438 @default.
• W2004507310 hasConcept C42219234 @default.
• W2004507310 hasConcept C50952357 @default.
• W2004507310 hasConcept C537181965 @default.
• W2004507310 hasConcept C71924100 @default.
• W2004507310 hasConcept C98274493 @default.
• W2004507310 hasConceptScore W2004507310C118552586 @default.
• W2004507310 hasConceptScore W2004507310C126322002 @default.
• W2004507310 hasConceptScore W2004507310C141071460 @default.
• W2004507310 hasConceptScore W2004507310C178790620 @default.
• W2004507310 hasConceptScore W2004507310C185592680 @default.
• W2004507310 hasConceptScore W2004507310C187212893 @default.
• W2004507310 hasConceptScore W2004507310C197934379 @default.
• W2004507310 hasConceptScore W2004507310C2776414672 @default.
• W2004507310 hasConceptScore W2004507310C2777803345 @default.
• W2004507310 hasConceptScore W2004507310C2778186239 @default.
• W2004507310 hasConceptScore W2004507310C2778375690 @default.

• next